Advertisement

Related Videos

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Deborah Collyar: What's In It for Patients?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Sep
02
Today In Oncology
Radiation to the Thymus in NSCLC Treatment May Increase Risk of Metastasis
Osimertinib Plus Chemotherapy Significantly Extends Progression-Free Survival in EGFR/TP53-Mutated NSCLC
Two Studies Build Evidence Supporting the Use of ctDNA as an Early Endpoint
The 2026 ASCO Annual Meeting Geriatric Oncology Update: The Next Challenge Is Implementation
Researchers Identify Donor NK Cell Subset That Impairs CAR NK Cell Therapy and Demonstrate a Manufacturing Solution
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo